UB Paderborn / Katalog / Suche / in CDI

HAS A 3-FOLD DECREASED DOSE OF BACILLUS CALMETTE-GUERIN THE SAME EFFICACY AGAINST RECURRENCES AND PROGRESSION OF T1G3 AND TIS BLADDER TUMORS THAN THE STANDARD DOSE? RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL

The Journal of urology, 2005-10, Vol.174 (4), p.1242-1247

2005

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data

European urology, 2005-08, Vol.48 (2), p.202-206

Vale, C.L.

2005

Volltextzugriff (PDF)

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

The Lancet (British edition), 2003-06, Vol.361 (9373), p.1927-1934

Vale, C

2003

Volltextzugriff (PDF)

Long‐term follow‐up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette‐Guérin with a reduced dose of 27 mg in superficial bladder cancer

BJU international, 2002-05, Vol.89 (7), p.671-680

2002

Volltextzugriff (PDF)

Determination of the Percentage of Free Prostate–Specific Antigen Helps to Avoid Unnecessary Biopsies in Men with Normal Rectal Examinations and Total Prostate–Specific Antigen of 4–10 ng/ml

European urology, 2000-03, Vol.37 (3), p.289-296

2000

Volltextzugriff (PDF)

Neoadjuvant chemotherapy for invasive bladder cancer

Cochrane database of systematic reviews, 2005-04 (2), p.CD005246

Advanced Bladder Cancer Overview Collaboration

2005

Volltextzugriff (PDF)

The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tables

International Brazilian journal of urology, 2011-10, Vol.37 (5), p.671-672

2011

Volltextzugriff (PDF)

The role of neoadjuvant chemotherapy for invasive bladder cancer

British Journal of Urology, 1998-07, Vol.82 (1), p.33-42

MartÍnez‐PIÑeiro

1998

Volltextzugriff (PDF)

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration

European urology, 2005-08, Vol.48 (2), p.202-5; discussion 205-6

2005

Volltextzugriff (PDF)

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration

European urology, 2005-08, Vol.48 (2), p.189-199; discussion 199-201

2005

Volltextzugriff (PDF)

Comentario editorial a «Artritis aguda secundaria a bacilo de Calmette-Guérin intravesical en el cáncer de vejiga

Actas urologicas españolas, 2012-09, Vol.36 (8), p.467-468

Martínez-Piñeiro, J.A

2012

Volltextzugriff (PDF)

Adjuvant Chemotherapy in Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data

European urology, 2005-08, Vol.48 (2), p.189-201

Vale, Claire L.

2005

Volltextzugriff (PDF)

Endourological Treatment of Upper Tract Urothelial Carcinomas: Analysis of a Series of 59 Tumors

The Journal of urology, 1996-08, Vol.156 (2), p.377-385

1996

Volltextzugriff (PDF)

Renal tubular acidosis in recurrrent renal stone formers

European urology, 1984-01, Vol.10 (1), p.55-59

1984

Volltextzugriff (PDF)

Transmural gastric migration of dual-sided PTFE/ePTFEE mesh after laparoscopic surgery for a recurrent hiatal hernia with dysphagia: case report

Chirurgia (Bucharest, Romania : 1990), 2014-07, Vol.109 (4), p.538-541

2014

Volltextzugriff (PDF)

Excision and Anastomotic Repair for Urethral Stricture Disease: Experience with 150 Cases

European urology, 1997-01, Vol.32 (4), p.433-441

1997

Volltextzugriff (PDF)

BCG Update: Intravesical Therapy

European urology, 1997-01, Vol.31 (Suppl 1), p.31-41

1997

Volltextzugriff (PDF)

Improving the Safety of BCG Immunotherapy by Dose Reduction

European urology, 1995, Vol.27 (Suppl 1), p.13-18

1995

Volltextzugriff (PDF)

Preliminary Results of a Comparative Study with Intracavernous Sodium Nitroprusside and Prostaglandin E1 in Patients with Erectile Dysfunction

The Journal of urology, 1995-05, Vol.153 (5), p.1487-1490

1995

Volltextzugriff (PDF)

Treatment techniques and controversies : panel discussion 2

European urology, 1992-05, Vol.21, p.43-44

MARTINEZ-PINEIRO, J.-A

1992

Volltextzugriff (PDF)

Bacillus Calmette-Guerin Versus Doxorubicin Versus Thiotepa: A Randomized Prospective Study in 202 Patients with Superficial Bladder Cancer

The Journal of urology, 1990-03, Vol.143 (3), p.502-506

1990

Volltextzugriff (PDF)

Nonspecific immunotherapy with BCG vaccine in bladder tumors: a preliminary report

European urology, 1977, Vol.3 (1), p.11

1977

Volltextzugriff (PDF)

Andrological implications of congenital posterior urethral valves in adults: a case of retained ejaculation and review in western literature

European urology, 1983, Vol.9 (6), p.359-361

1983

Volltextzugriff (PDF)

Fluorescence Urinary Cytology in Bladder Cancer

European urology, 1977-01, Vol.3 (3), p.142-144

1977

Volltextzugriff (PDF)

Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG)

Cancer chemotherapy and pharmacology, 1983-01, Vol.11 Suppl (S1), p.S25-S31

1983

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

HAS A 3-FOLD DECREASED DOSE OF BACILLUS CALMETTE-GUERIN THE SAME EFFICACY AGAINST RECURRENCES AND PROGRESSION OF T1G3 AND TIS BLADDER TUMORS THAN THE STANDARD DOSE? RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL

Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

Long‐term follow‐up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette‐Guérin with a reduced dose of 27 mg in superficial bladder cancer

Determination of the Percentage of Free Prostate–Specific Antigen Helps to Avoid Unnecessary Biopsies in Men with Normal Rectal Examinations and Total Prostate–Specific Antigen of 4–10 ng/ml

Neoadjuvant chemotherapy for invasive bladder cancer

The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tables

The role of neoadjuvant chemotherapy for invasive bladder cancer

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration

Comentario editorial a «Artritis aguda secundaria a bacilo de Calmette-Guérin intravesical en el cáncer de vejiga

Adjuvant Chemotherapy in Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data

Endourological Treatment of Upper Tract Urothelial Carcinomas: Analysis of a Series of 59 Tumors

Renal tubular acidosis in recurrrent renal stone formers

Transmural gastric migration of dual-sided PTFE/ePTFEE mesh after laparoscopic surgery for a recurrent hiatal hernia with dysphagia: case report

Excision and Anastomotic Repair for Urethral Stricture Disease: Experience with 150 Cases

BCG Update: Intravesical Therapy

Improving the Safety of BCG Immunotherapy by Dose Reduction

Preliminary Results of a Comparative Study with Intracavernous Sodium Nitroprusside and Prostaglandin E1 in Patients with Erectile Dysfunction

Treatment techniques and controversies : panel discussion 2

Bacillus Calmette-Guerin Versus Doxorubicin Versus Thiotepa: A Randomized Prospective Study in 202 Patients with Superficial Bladder Cancer

Nonspecific immunotherapy with BCG vaccine in bladder tumors: a preliminary report

Andrological implications of congenital posterior urethral valves in adults: a case of retained ejaculation and review in western literature

Fluorescence Urinary Cytology in Bladder Cancer

Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG)

Suchergebnisse filtern